Low-molecular-weight heparin (LMWH) is a safe and effective alternative to unfractionated heparin and coumadin in the treatment and prophylaxis of thrombosis in children. When compared with these more established anticoagulants, it is easier to achieve therapeutic levels and the incidence of hemorrhagic complications is equivalent or lower. In children there is less published experience than in adults, but the low frequency of significant bleeding appears to be similar. The authors describe a child on therapeutic doses of LMWH for a deep vein thrombosis who spontaneously developed an intramural hemorrhage in his small bowel, leading to infarction and a partial bowel resection.
|Original language||English (US)|
|Number of pages||3|
|Journal||Journal of Pediatric Hematology/Oncology|
|State||Published - Oct 1 2005|
- Low-molecular-weight heparin
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health